Skip to content
1887

Abstract

Metagenomics is increasingly used for diagnosis in hospital settings. It is useful particularly in cases of unknown aetiology, where novel or difficult-to-diagnose pathogens are suspected, and/or following unexplained disease outbreaks. In this paper, we present three use cases that draw on existing reports: one involving a patient in intensive care with encephalitis of unknown aetiology; a second case with likely infection with drug-resistant and an incidental finding of unknown relevance; and a third case situated in an unexplained outbreak of acute hepatitis in children, with severe outcomes due to co-infection. We examine each case in turn, highlighting ethical questions arising in relation to clinical issues including: disclosure to patients of untreatable disease, cost-effectiveness, the value of resistance testing, sensitivity and specificity, uncertain or unexpected findings, patient consent and data sharing. We conclude by proposing recommendations for further research and developing particular pieces of guidance to improve clinical uses of metagenomics for diagnosis.

Funding
This study was supported by the:
  • National Health and Medical Research Council (Award Early Investigator)
    • Principle Award Recipient: PrashanthRamachandran
  • Wellcome Trust (Award 221038/Z/20/Z])
    • Principle Award Recipient: StephanieJohnson
  • Moh Family Foundation (Award Pandemic Sciences Institute Trust and Confidence Theme)
    • Principle Award Recipient: EuzebiuszJamrozik
  • Moh Family Foundation (Award Pandemic Sciences Institute Trust and Confidence Theme)
    • Principle Award Recipient: TessJohnson
  • Wellcome Trust (Award 221719)
    • Principle Award Recipient: EuzebiuszJamrozik
  • Wellcome Trust (Award 221719)
    • Principle Award Recipient: TessJohnson
  • Wellcome Trust (Award 203132)
    • Principle Award Recipient: EuzebiuszJamrozik
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001967
2025-02-27
2025-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/2/jmm001967.html?itemId=/content/journal/jmm/10.1099/jmm.0.001967&mimeType=html&fmt=ahah

References

  1. Ko KKK, Chng KR, Nagarajan N. Metagenomics-enabled microbial surveillance. Nat Microbiol 2022; 7:486–496 [View Article] [PubMed]
    [Google Scholar]
  2. Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol Mech Dis 2019; 14:319–338 [View Article]
    [Google Scholar]
  3. Brown JR, Bharucha T, Breuer J. Encephalitis diagnosis using metagenomics: application of next generation sequencing for undiagnosed cases. J Infect 2018; 76:225–240 [View Article]
    [Google Scholar]
  4. Charalampous T, Alcolea-Medina A, Snell LB, Alder C, Tan M et al. Routine metagenomics service for ICU patients with respiratory infection. Am J Respir Crit Care Med 2024; 209:164–174 [View Article]
    [Google Scholar]
  5. Matthews PC, Campbell C, Săndulescu O, Matičič M, Ruta SM et al. Acute severe hepatitis outbreak in children: a perfect storm. what do we know, and what questions remain?. Front Pharmacol 2022; 13:1062408 [View Article] [PubMed]
    [Google Scholar]
  6. Milne R, Patch C. Ethical challenges associated with pathogen and host genetics in infectious disease. New Bioeth 2023; 29:24–36 [View Article] [PubMed]
    [Google Scholar]
  7. Leon KE, Schubert RD, Casas-Alba D, Hawes IA, Ramachandran PS et al. Genomic and serologic characterization of enterovirus A71 brainstem encephalitis. Neurol Neuroimmunol Neuroinflamm 2020; 7: [View Article]
    [Google Scholar]
  8. Hall RJ, Draper JL, Nielsen FGG, Dutilh BE. Beyond research: a primer for considerations on using viral metagenomics in the field and clinic. Front Microbiol 2015; 6:224 [View Article] [PubMed]
    [Google Scholar]
  9. Jamrozik E, Selgelid MJ. Invisible epidemics: ethics and asymptomatic infection. Monash Bioeth Rev 2020; 38:1–16 [View Article] [PubMed]
    [Google Scholar]
  10. Méthot P-O, Alizon S. What is a pathogen? Toward a process view of host-parasite interactions. Virulence 2014; 5:775–785 [View Article] [PubMed]
    [Google Scholar]
  11. Kim K-W, Ahn S-W, Park K-Y, Youn YC, Shin H-W. Enteroviral encephalitis presenting as rapidly progressive aphasia. J Neurol Sci 2012; 319:156–157 [View Article] [PubMed]
    [Google Scholar]
  12. Magiorkinis G, Matthews PC, Wallace SE, Jeffery K, Dunbar K et al. Potential for diagnosis of infectious disease from the 100,000 genomes project metagenomic dataset: recommendations for reporting results. Wellcome Open Res 2019; 4:155 [View Article] [PubMed]
    [Google Scholar]
  13. Han D, Yu F, Zhang D, Yang Q, Xie M et al. The real-world clinical impact of plasma mNGS testing: an observational study. Microbiol Spectr 2023; 11:e0398322 [View Article] [PubMed]
    [Google Scholar]
  14. Shaw MW. Testing for the Huntington gene: a right to know, a right not to know, or a duty to know. Am J Med Genet 1987; 26:243–246 [View Article] [PubMed]
    [Google Scholar]
  15. World Health Organization Drug-resistant TB and HIV. In Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug Resistant Tuberculosis Geneva: World Health Organization; 2014 https://iris.who.int/handle/10665/130918 accessed 25 October 2024
    [Google Scholar]
  16. Keshi L, Weiwei X, Shoulin L, Xiadong L, Hao W et al. Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection. Saudi Med J 2019; 40:1111–1115 [View Article] [PubMed]
    [Google Scholar]
  17. Rump B, Timen A, Hulscher M, Verweij M. Ethics of infection control measures for carriers of antimicrobial drug–resistant organisms. Emerg Infect Dis 2018; 24:1609–1616 [View Article]
    [Google Scholar]
  18. Bharucha T, Oeser C, Balloux F, Brown JR, Carbo EC et al. STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies. Lancet Infect Dis 2020; 20:e251–e260 [View Article]
    [Google Scholar]
  19. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015; 351:h5527 [View Article] [PubMed]
    [Google Scholar]
  20. Cameron A, Bohrhunter JL, Taffner S, Malek A, Pecora ND et al. Clinical pathogen genomics. Clin Lab Med 2020; 40:447–458 [View Article] [PubMed]
    [Google Scholar]
  21. Keita AK, Raoult D, Fenollar F. Tropheryma whipplei as a commensal bacterium. Future Microbiol 2013; 8:57–71 [View Article] [PubMed]
    [Google Scholar]
  22. Marth T. Systematic review: Whipple’s disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors. Aliment Pharmacol Ther 2015; 41:709–724 [View Article]
    [Google Scholar]
  23. Dolmans Ruben AV, Boel CHE, Lacle Miangela M, Kusters Johannes G. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev 2017; 30:529–555 [View Article]
    [Google Scholar]
  24. Ramachandran PS, Wilson MR. Metagenomics for neurological infections - expanding our imagination. Nat Rev Neurol 2020; 16:547–556 [View Article] [PubMed]
    [Google Scholar]
  25. Biesecker BB, Klein W, Lewis KL, Fisher TC, Wright MF et al. How do research participants perceive “uncertainty” in genome sequencing?. Genet Med 2014; 16:977–980 [View Article] [PubMed]
    [Google Scholar]
  26. Newson AJ, Leonard SJ, Hall A, Gaff CL. Known unknowns: building an ethics of uncertainty into genomic medicine. BMC Med Genom 2016; 9:57 [View Article] [PubMed]
    [Google Scholar]
  27. World Health Organization Severe acute hepatitis of unknown origin in children – multicountry. News report 2022 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376 accessed 25 October 2024
    [Google Scholar]
  28. World Health Organization Update: severe acute hepatitis of unknown aetiology in children - multi-country. News report 2022 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400 accessed 25 October 2024
    [Google Scholar]
  29. Morfopoulou S, Buddle S, Torres Montaguth OE, Atkinson L, Guerra-Assunção JA et al. Genomic investigations of unexplained acute hepatitis in children. Nature 2023; 617:564–573 [View Article] [PubMed]
    [Google Scholar]
  30. Gu W, Rauschecker AM, Hsu E, Zorn KC, Sucu Y et al. Detection of neoplasms by metagenomic next-generation sequencing of cerebrospinal fluid. JAMA Neurol 2021; 78:1355–1366 [View Article] [PubMed]
    [Google Scholar]
  31. The Health Service (Control of Patient Information) Regulations 2002. Legislation.gov.uk n.d https://www.legislation.gov.uk/uksi/2002/1438/contents accessed 25 October 2024
    [Google Scholar]
  32. World Health Organization Health Ethics and Governance Unit WHO guidelines on ethical issues in public health surveillance. Geneva: WHO; 2017 https://www.who.int/publications/i/item/9789241512657 accessed 25 October 2024
  33. Johnson SB, Slade I, Giubilini A, Graham M. Rethinking the ethical principles of genomic medicine services. Eur J Hum Genet 2020; 28:147–154 [View Article] [PubMed]
    [Google Scholar]
  34. NHS England Whole genome sequencing for children – an information guide for parents, carers and families; 2023 https://www.england.nhs.uk/long-read/whole-genome-sequencing-for-children-an-information-guide-for-parents-carers-and-families/ accessed 25 October 2024
  35. Eichinger J, Elger BS, Koné I, Filges I, Shaw D et al. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021; 21:387 [View Article] [PubMed]
    [Google Scholar]
  36. Liu X, Chen Y, Ouyang H, Liu J, Luo X et al. Tuberculosis diagnosis by metagenomic next-generation sequencing on bronchoalveolar lavage fluid: a cross-sectional analysis. Int J Infect Dis 2021; 104:50–57 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001967
Loading
/content/journal/jmm/10.1099/jmm.0.001967
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error